Systematic Reviews
Copyright ©The Author(s) 2020.
World J Clin Oncol. Apr 24, 2020; 11(4): 217-242
Published online Apr 24, 2020. doi: 10.5306/wjco.v11.i4.217
Table 5 Paper results for non- case-controlled studies on obesity and physical activity in association with breast cancer
Ref.Type of studySample size and characteristicsAge range (mean ± SD)Anthropometric measurementsPAKey findingsOther findings
[81]Single-institute retrospective study224 females (72.4% Saudi National) who underwent mastectomy, MRM or WLE with axillary dissection26-93 yr (48.8 ± 12.2); 61.7% of females < 50 yrMean BMI; 32; 38.3% overweight; 42.8% obeseN/AMost of the participants in both age groups had a BMI > 3092.6% of females had invasive BC; Ten-year survival rate did not differ significantly with females ≤ 45 or > 45. Only 12% of patients presented with early-stage disease
[42]Data-analysis of patients treated with BCS and MRM between February 1988 and August 2008112 Saudi women. Not included if had distant metastasis or neoadjuvant chemotherapy23-76 yr (47.0 ± 10.3)Range: 15-52.8; Mean BMI (± SD): 31.8 (± 7.2); 28.6% overweight 53.6% obeseN/ABMI < 18.5 was significantly associated (P = 0.002) to locoregional recurrences; BMI 26-30 (overweight) was significantly associated with locoregional recurrence (P = 0.002); In multivariate analysis age < 35 was an independent risk factor for locoregional recurrence. The risk of locoregional recurrence was not significant in obese femalesOnly 8.93% had locoregional recurrences, 83% of women were premenopausal and 17% were postmenopausal
[43]Retrospective cross-sectional secondary data analysis study112 Saudi women diagnosed with BC that had either BCS with axillary lymph node dissection or MRM following neoadjuvant therapyNo range; 47 ± 10Mean BMI (± SD): 32 (± 7.16); 27.3% overweight 56.4% obeseN/ABC receptor expression was not influenced by BMIObesity did not influence the TNM stage of the breast tumour; 82.7% of the sample were premenopausal and 17.3% were postmenopausal